Screener / SEC EDGAR /CIK 0000916540 /10-K filed Mar 3, 2026, compared with Feb 25, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Consumer staples · Agricultural Products

Darling Ingredients Inc. DAR

Compare with peers Embed
The 10-K against last year's

248 changes: 21 added, 22 removed, 200 reworded, 5 quiet changes

10-K Mar 3, 2026 vs Feb 25, 2025

10-K 0000916540-26-000008 (Mar 3, 2026) vs 10-K 0000916540-25-000008 (Feb 25, 2025)

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

268 paragraphs · 16 new · 120 reworded · 17 gone · 10-K Mar 3, 2026 against Feb 25, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 236 · 49% changed Every version of it
We may face difficulty in fully complying with these regulations and any failure to do so could subject us to significant monetary penalties, liabilities, and adverse publicity. In the United States, the California Consumer Privacy Act (“CCPA”) is a far-reaching data privacy law, which has been significantly (“CCPA”), as amended by the California Privacy Rights Act (“CPRA”). The full impact of the amended CCPA on us and others in our industry remains uncertain because regulations that are necessary to fully implement the law have not been finalized. Those include regulations that would be the first in the US to comprehensively regulate the use of artificial intelligence when used to make decisions about individuals. (“CPRA”), is a far-reaching data privacy regime. In addition to California, other several states have passed similar comprehensive data privacy laws, some of which are currently in effect and others that will take effect over the next two years; meanwhile, while other states continue to evaluate the enactment of other data privacy and cybersecurity laws. California and other states are also expanding their laws to regulate the use of AI, including when AI is used to make decisions about individuals. These state laws and their regulations continue to evolve and be enacted at a rapid pace, which can make compliance difficult and costly. Additionally, the Federal Trade Commission (“FTC”) and many state attorneys general are interpreting existing federal and state consumer protection laws to impose evolving standards for the apply to collection, use, dissemination and security of personal information. We U.S. policymakers and regulators are also expect additional laws and regulations to be passed regulating various uses of artificial intelligence, including as described in the October 2023 White House Executive Order increasingly focused on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence. In addition, in August 2024, EU Regulation 2024/1689 on artificial intelligence (“EU AI Act”) entered into force. Most of the rules will go into effect in August 2026. The EU AI Act governs the development and deployment of AI placed on the EU market, used in the EU, or where the output is used or intended to be used within the EU. The EU AI Act aims to ensure the safe and ethical development trustworthy use of artificial intelligence technologies, AI, with growing state-level adoption of AI-specific legislation, including in states such as Colorado, Utah and establishes a risk-based regulatory framework, categorizing artificial intelligence systems into four levels of risk (i.e., unacceptable, high, limited and minimal). In case of non-compliance, the fine threshold is set at 35 million euros or 7% of total annual worldwide turnover, whichever is higher, and regulators have the power to remove non-compliant products from the EU market. Achieving compliance with the EU AI Act California. These developments may require significant investments in adapting artificial intelligence systems changes to meet regulatory requirements. This could include implementing enhanced data governance, ensuring human oversight, our business practices and providing detailed technical documentation, which may increase costs and deployment timelines. The impact of these cybersecurity, privacy, and artificial intelligence laws and orders on us and others in our industry is uncertain. We also may be required to increased compliance costs.
Paragraph 175 · 49% changed Every version of it
•exposing us to the risk of increased interest rates as certain of our borrowings are at debt has a variable rates rate of interest; interest and as we refinance our debt that has a fixed rate of interest, which could increase our debt service obligations and negatively impact our net income and cash flows;
Paragraph 121 · 48% changed Every version of it
Furthermore, emerging there is legislation seeks to regulate corporate environmental, social, and governance (“ESG”) practices, including (and additional legislation has been introduced) regulating practices related to the causes and impacts of climate change as well as supply chain control and compliance with human rights. For example, in December 2022 the EU adopted Directive (EU) 2022/2464 amending Regulation (EU) No 537/2014, Directive 2004/109/EC, Directive 2006/43/EC and Directive 2013/34/EU, 2022/2464, also known as the Corporate Sustainability Reporting Directive (“CSRD”). The new rules, (“CSRD”), which apply to all large (EU and non-EU) companies with significant activities in the EU and to EU-listed small and medium-sized enterprises, require companies to report requires reporting on how sustainability issues (environmental, social, and governance) affect their business and about their own impact on people and the environment. sustainability-related issues. In addition, in May June 2024 the EU adopted Directive (EU) 2024/1760, also known as the Corporate Sustainability Due Diligence Directive (“CSDDD”). The CSDDD will become gradually applicable starting in 2027 to large (EU and non-EU) companies and parent companies meeting specific thresholds. The new rules require in-scope companies to conduct (“CSDDD”), which requires risk-based supply chain due diligence in order to identify, prevent, mitigate and remediate actual and potential adverse impacts on people and the environment resulting from the operations of the company, its subsidiaries and business partners certain activities in the Company’s supply chain. In-scope In addition, there has been increased state-level legislation in the U.S., like California’s SB 261, which mandates certain companies are also required doing business in California to adopt disclose climate-related financial risks, and implement a climate transition plan, setting out a strategy SB 253, which requires reporting of corporate greenhouse gas emissions. In both the EU and California the regulations have been delayed pending amendments and legal challenges, which increases the uncertainty around final impacts to reduce emissions the Company. The Company continues to monitor proposed changes to these and other proposed legislative and regulatory requirements related to sustainability issues in line state and national jurisdictions. Compliance with the Paris Agreement targets. CSRD, CSDDD, California’s SB 261 and SB 253, and other proposed or adopted legislative and regulatory requirements related to sustainability issues may require expenditures that could materially adversely affect our business, results of operations and financial condition. There has also been increased focus from our stakeholders, including consumers, customers, suppliers, employees and investors, on our sustainability and ESG practices. We expect that stakeholder expectations with respect to sustainability and ESG will continue to evolve rapidly, progress, which may necessitate additional resources to monitor, report on, and adjust our operations.
Paragraph 51 · 47% changed Every version of it
The prices available for the Company’s Food Ingredients segment’s collagen, edible fats and natural casings products are influenced by other competing ingredients, including plant-based and synthetic hydrocolloids and artificial casings. In the collagen operation, in particular, the cost of the Company’s animal-based raw material moves in relationship to the selling price of the finished goods. The processing time for the Food Ingredients segment's collagen and casings is generally 30 to 60 days, which is substantially longer than the Company’s Feed Ingredients segment's animal by-products operations. Consequently, the Company’s gross margin and profitability in this segment can be influenced by the movement of finished goods prices during the period from when the raw materials were procured until the finished goods are sold.
Paragraph 140 · 46% changed Every version of it
financial condition and results of operations. For example, we have received notices from the EPA relating to alleged sediment contamination in Newtown Creek in New York and alleged river sediment contamination in the Lower Passaic River area of New Jersey, and are party to a lawsuit filed by Occidental Chemical Corporation in which it seeks contribution for various investigative and cleanup costs it has incurred in connection with the Lower Passaic River area of New Jersey. See Item 3. “Legal Proceedings” for additional information about the Lower Passaic River matter. In addition, future developments, such as more aggressive enforcement policies, new laws or discoveries of currently unknown contamination conditions, may also require expenditures that may have a material adverse effect on our business and financial condition. For example, regulations are newly emerging regarding per- and polyfluoroalkyl substances (“PFAS”) due to potential health and environmental risks. In April 2024, the EPA adopted a rule designating two widely used PFAS – perfluorooctanoic acid (“PFOA”) and perfluorooctanesulfonic acid (“PFOS”) – as “hazardous substances” under CERCLA and adopted the primary drinking water standard for PFAS. In the EU, because only certain subgroups of PFAS are currently regulated at the EU level, the EU legislators are taking steps to adopt a comprehensive legislative measure simultaneously restricting a large number of PFAS. In February 2023, the European Chemical Agency (“ECHA”) published a proposal to restrict 10,000+ PFAS under Annex XVII of Regulation (EC) No. 1907/2006 concerning the registration, evaluation, authorization and restriction of Chemicals (“REACH”). ECHA’s committees for Risk Assessment and Socio-Economic Analysis are currently have been evaluating the proposal based on a sector-based approach to address the specificities of such substances, and a consolidated opinion will be sent to the European Commission, which will make the ultimate decision in consultation with the EU Member States. Further consultations and evaluations are expected to continue in 2025 and beyond. While Darling does not manufacture or use PFAS substances, PFAS, the raw materials we process could contain PFAS as could the influent waters from city supply services and/or production wells. If PFAS is contained in these sources, it could persist in the outputs of our production, including wastewater treatment discharges, wastewater-derived residuals, and/or finished products. There can be no assurance that we will not face costs New or penalties regarding expanded regulation, enforcement actions, remediation obligations, product impacts or private litigation related to PFAS that would have a could result in material adverse effect on our financial condition and results of operations. We could also be subject to odor related claims, damages, violations and/or penalties, including potential class action odor litigation. costs, operational disruptions or reputational harm.
Paragraph 124 · 46% changed Every version of it
We and our customers for whom we manufacture products may be exposed to product liability or other claims, product recalls and adverse public relations if consumption or use of our products is alleged to cause injury or illness to humans or animals. In addition, we and our customers may be subject to product liability or other claims, product recalls, and adverse public relations resulting from developments relating to the discovery of unauthorized adulterations to food additives or other products or from allegations that our food ingredients or other products were mislabeled, were not produced in accordance with the customer’s specifications, contract requirements or regulatory standards and/or have not performed adequately in the end product, even where food safety or other product safety is not a concern. In some cases, we indemnify our customers for product liability and other claims related to our products. Product recalls in one jurisdiction may result in product recalls in other jurisdictions, as is the case in the EU, where the European Commission and the EU Member States exchange information about recalls. Our insurance may not cover or be adequate to cover all liabilities we incur in connection with product liability and/or other claims, whether or not legitimate, or product recalls, whether voluntary or mandatory, and we may not be able to maintain our existing insurance or obtain comparable insurance at a reasonable cost for such matters. A judgment against us or against one of our customers for whom we manufacture or provide products on a product liability or other claim, or our or their agreement to settle a product liability or other claim, or a product recall, could also result in substantial and unexpected expenditures, which would reduce operating income and cash flow. In addition, even if product liability or other claims against us or our customers for whom we manufacture products are not successful or are not fully pursued, defending these claims would likely be costly and time-consuming and may require significant management attention.
Paragraph 66 · 46% changed Every version of it
The DGD Joint Venture is subject to and dependent on governmental energy policies and programs, such as the National Renewable Fuel Standard Program (“RFS”) and low carbon fuel standards (“LCFS”) (such as those in place in the state of California), which positively impact the demand for and price of renewable diesel. Any changes to, a failure to enforce or a discontinuation of any of these programs could have a material adverse effect on the DGD Joint Venture. Further, these programs are regularly subject to expirations and renewals which, at any time, could be delayed or not renewed, and other administrative and political review which could result in limitations or other policy adjustments by the respective administrations overseeing them. See the section entitled “Risk Factors-Risks Related to the Company-Our our Business-Our renewable energy businesses may be affected by energy policies around the world.” Additionally, there may be new entrants into the renewable fuels industry or new technologies developed that could meet demand for lower-carbon transportation fuels and modes of transportation in a more efficient or less costly manner than our technologies and products, which could also have a material adverse effect on businesses, including the DGD Joint Venture. For instance, several other companies have made, or announced interest in making, investments in renewable diesel projects. Should these projects develop, the DGD Joint Venture would face competition from them for feedstocks Venture, are highly dependent on government programs, incentives and customers, regulatory frameworks, which could strain margins on the products it sells are subject to change and limit the growth and profitability of the DGD Joint Venture. It is not possible at this time to predict the ultimate form, timing, or extent of any such developments; however, a reduction in the demand for the DGD Joint Venture’s products as a result of any of the foregoing events could materially and adversely affect our business, financial condition, results of operations, and liquidity. uncertainty.”
Paragraph 139 · 45% changed Every version of it
financial condition and results of operations. For example, we have received notices from the EPA relating to alleged sediment contamination in Newtown Creek in New York and alleged river sediment contamination in the Lower Passaic River area of New Jersey, and are party to a lawsuit filed by Occidental Chemical Corporation in which it seeks contribution for various investigative and cleanup costs it has incurred in connection with the Lower Passaic River area of New Jersey. See Item 3. “Legal Proceedings” for additional information about the Lower Passaic River matter. In addition, future developments, such as more aggressive enforcement policies, new laws or discoveries of currently unknown contamination conditions, may also require expenditures that may have a material adverse effect on our business and financial condition. For example, regulations are newly emerging regarding per- and polyfluoroalkyl substances (“PFAS”) continue to evolve due to potential health and environmental risks. In April 2024, the U.S., the EPA adopted a rule designating two widely used PFAS – has designated perfluorooctanoic acid (“PFOA”) and perfluorooctanesulfonic acid (“PFOS”) – as “hazardous substances” under CERCLA and adopted the primary drinking water standard standards for PFAS. In certain PFAS, with which public water systems must comply by 2029. The EPA is also advancing regulations to list certain PFAS as hazardous constituents under the EU, because only certain subgroups of PFAS are currently regulated at the EU level, the Resource Conservation and Recovery Act (RCRA). EU legislators are taking steps to adopt a comprehensive legislative measure simultaneously restricting a large number of PFAS. In February 2023, the European Chemical Agency (“ECHA”) published a proposal to restrict 10,000+ PFAS under Annex XVII of Regulation (EC) No. 1907/2006 concerning the registration, evaluation, authorization and restriction of Chemicals (“REACH”). ECHA’s committees for Risk Assessment and Socio-Economic Analysis are currently evaluating the proposal based on a sector-based approach to address the specificities of such substances, and a consolidated opinion will be sent to the European Commission, which will make the ultimate decision in consultation with the EU Member States. Further consultations and evaluations are expected to continue in 2025 and beyond. While Darling does not manufacture or use PFAS substances, the raw materials we process could contain PFAS as could the influent waters from city supply services and/or production wells. If PFAS is contained in these sources, it could persist in the outputs of our production, including wastewater treatment discharges, wastewater-derived residuals, and/or finished products. There can be no assurance that we will not face costs or penalties regarding PFAS that would have a material adverse effect on our financial condition and results of operations. We could also be subject to odor related claims, damages, violations and/or penalties, including potential class action odor litigation.

MD&A

112 paragraphs · 5 new · 79 reworded · 5 gone · 10-K Mar 3, 2026 against Feb 25, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 48 · 41% changed
Other Income, net. Other income was $22.3 $0.5 million for fiscal year 2024, 2025, compared to other income of $16.3 $22.3 million in fiscal year 2023. 2024. The increase decrease in other income was primarily due to a decrease in casualty loss insurance proceeds received for fires which occurred in late 2022 at gains and the impact of current year settlement losses from the termination of two of the Company’s Tacoma, Washington and Ward, South Carolina facilities, as well as current year flooding in Brazil domestic defined benefit pension plans that was partially offset by a decrease in interest income, an increase in gain from the non-service component sale of pension expense and an increase in other miscellaneous non-operating expenses a portion of a minor international subsidiary as compared to fiscal year 2023. 2024.
Paragraph 105 · 41% changed
The Company has retirement and pension plans covering a substantial number of its domestic and foreign employees. Major assumptions used in the accounting for these employee benefit plans include the discount rate, expected return on plan assets, rate of increase in employee compensation levels, mortality rates and trends in health care costs. The actuarial assumptions used may differ materially from actual results due to changing market and economic conditions, higher or lower withdrawal rates or longer or shorter life spans of participants. These differences may result in a significant impact to the amount of net periodic benefit cost recorded in future periods.
Paragraph 79 · 39% changed
Based upon the annual actuarial estimate, current accruals and claims paid during fiscal year 2024, the Company has accrued approximately $21.2 million as of December 28, 2024 that it expects will become due during the next twelve months in order to meet obligations related to the Company’s self-insurance reserves and accrued insurance obligations, which are included in current accrued expenses at December 28, 2024. The self-insurance reserve is composed of estimated liability for claims arising for workers’ compensation, auto liability, general liability and medical claims liability. The self-insurance reserve liability and medical claims liability are determined annually, based upon a third-party actuarial estimate. The actuarial estimate may vary from year to year, due to changes in costs of health care, the pending number of claims and other factors beyond the control of management of the Company.
Paragraph 45 · 38% changed
Acquisition and Integration Costs. Acquisition and integration costs were approximately $15.9 million during fiscal year 2025 as compared to $7.8 million during fiscal year 2024 2024. These costs primarily related to the announced joint venture between the Company and the Tessenderlo Group NV for fiscal year 2025 as compared to $13.9 million during costs related to the Gelnex acquisition, the Miropasz Group acquisition and other acquisitions for fiscal year 2023. Fiscal 2024 costs include Miropasz and other acquisition costs along with integration costs associated with the Gelnex Acquisition which were lower than fiscal 2023 costs which included Gelnex acquisition costs along with integration costs associated with the FASA and Valley Acquisitions. 2024.
Paragraph 65 · 36% changed
•As of December 28, 2024, January 3, 2026, the Company has borrowed all $400.0 $900.0 million under the terms of the term A-1 A facility and has repaid $3.0 $4.5 million, which when repaid by the Company cannot be reborrowed. The term A-1 A facility borrowings are repayable in quarterly installments of 0.25% of the aggregate principle amount of the relevant term A-1 A facility on the last day of each March, June, September and December of each year commencing on the last day of such month falling on or after the last day of the first full fiscal quarter following the second anniversary of December 9, 2021 and continuing until the last day of such quarterly period ending immediately prior to the term A-1 facility maturity date of December 9, 2026 and one final installment in the amount of the term A-1 facility then outstanding, due and payable on December 9, 2026.
Paragraph 109 · 36% changed
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) Improvements to Income Tax Disclosures, which expands Disclosures. The ASU requires the disclosures required annual financial statements to include consistent categories and greater disaggregation of information in an entity's income tax the rate reconciliation table reconciliation, and disclosure of income taxes paid both in U.S. and foreign jurisdictions. The amendments are disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years the Company's annual reporting periods beginning after December 15, 2024 and should be applied prospectively. 2024. Adoption is either with a prospective method or a fully retrospective method of transition. Early adoption is permitted. The Company is currently evaluating adopted this ASU, but does ASU in 2025 using the prospective method and the adoption did not expect this update to have a material an impact on the Company’s consolidated financial statements other than additional information that is provided in the footnote disclosure.
Paragraph 37 · 36% changed
Segment operating income. The Company’s Food Ingredients segment operating income was $144.7 $151.8 million for fiscal year 2024, a decrease 2025, an increase of $(66.9) $7.1 million or (31.6)% 4.9% as compared to fiscal year 2023. 2024. The decrease increase in operating income was primarily due to lower prices for collagen, increased sales volumes and the impact of an out-of-period the out of period inventory expense adjustment to prior year’s cost of sales and operating expenses that more than offset the increase in restructuring and impairment charges primarily related to our natural casings business of approximately $25.1 million and an increase in depreciation and amortization as compared to fiscal 2023. $25.6 million.
Paragraph 36 · 35% changed
Segment operating income. The Company’s Margins. In the Food Ingredients segment operating income was $144.7 million for fiscal year 2024, a decrease of $(66.9) million or (31.6)% 2025, the gross margin percentage increased to 27.7% as compared to 25.1% for fiscal year 2023. 2024. The decrease increase in margin was primarily due to lower prices for collagen, the impact of an out-of-period out of period inventory expense adjustment of approximately $25.1 million to the prior year’s cost of sales and an increase in depreciation and amortization as compared to fiscal 2023. operating expenses.

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 8 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

Risk Factors423 words changed in this paragraph; it is 33% similar to last year's version.
We may face difficulty in fully complying with these regulations and any failure to do so could subject us to significant monetary penalties, liabilities, and adverse publicity. In the United States, the California Consumer Privacy Act (“CCPA”) is a far-reaching data privacy law, which has been significantly (“CCPA”), as amended by the California Privacy Rights Act (“CPRA”). The full impact of the amended CCPA on us and others in our industry remains uncertain because regulations that are necessary to fully implement the law have not been finalized. Those include regulations that would be the first in the US to comprehensively regulate the use of artificial intelligence when used to make decisions about individuals. (“CPRA”), is a far-reaching data privacy regime. In addition to California, other several states have passed similar comprehensive data privacy laws, some of which are currently in effect and others that will take effect over the next two years; meanwhile, while other states continue to evaluate the enactment of other data privacy and cybersecurity laws. California and other states are also expanding their laws to regulate the use of AI, including when AI is used to make decisions about individuals. These state laws and their regulations continue to evolve and be enacted at a rapid pace, which can make compliance difficult and costly. Additionally, the Federal Trade Commission (“FTC”) and many state attorneys general are interpreting existing federal and state consumer protection laws to impose evolving standards for the apply to collection, use, dissemination and security of personal information. We U.S. policymakers and regulators are also expect additional laws and regulations to be passed regulating various uses of artificial intelligence, including as described in the October 2023 White House Executive Order increasingly focused on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence. In addition, in August 2024, EU Regulation 2024/1689 on artificial intelligence (“EU AI Act”) entered into force. Most of the rules will go into effect in August 2026. The EU AI Act governs the development and deployment of AI placed on the EU market, used in the EU, or where the output is used or intended to be used within the EU. The EU AI Act aims to ensure the safe and ethical development trustworthy use of artificial intelligence technologies, AI, with growing state-level adoption of AI-specific legislation, including in states such as Colorado, Utah and establishes a risk-based regulatory framework, categorizing artificial intelligence systems into four levels of risk (i.e., unacceptable, high, limited and minimal). In case of non-compliance, the fine threshold is set at 35 million euros or 7% of total annual worldwide turnover, whichever is higher, and regulators have the power to remove non-compliant products from the EU market. Achieving compliance with the EU AI Act California. These developments may require significant investments in adapting artificial intelligence systems changes to meet regulatory requirements. This could include implementing enhanced data governance, ensuring human oversight, our business practices and providing detailed technical documentation, which may increase costs and deployment timelines. The impact of these cybersecurity, privacy, and artificial intelligence laws and orders on us and others in our industry is uncertain. We also may be required to increased compliance costs.

Source: Item 1A, 10-K 0000916540-26-000008 vs Item 1A, 10-K 0000916540-25-000008

Legal Proceedings396 words changed in this paragraph; it is 67% similar to last year's version.
Lower Passaic River Area. In December 2009, the Company, along with numerous other entities, received notice from the United States Environmental Protection Agency (“EPA”) that the Company (as alleged successor-in-interest to The Standard Tallow Corporation) is considered a potentially responsible party (a “PRP”) with respect to alleged contamination in the lower 17-mile area of the Passaic River (the “Lower Passaic River”) which is part of the Diamond Alkali Superfund Site located in Newark, New Jersey. The Company’s designation as a PRP is based upon the operation of former plant sites located in Newark and Kearny, New Jersey by The Standard Tallow Corporation, an entity that the Company acquired in 1996. In March 2016, the Company received another letter from the EPA notifying the Company that it had issued a Record of Decision (the “ROD”) selecting a remedy for the lower 8.3 miles of the Lower Passaic River area at an estimated cost of $1.38 billion. The EPA letter made no demand on the Company and laid out a framework for remedial design/remedial action implementation under which the EPA would first seek funding from major PRPs. The letter indicated that the EPA had sent the letter to over 100 parties, which include large chemical and refining companies, manufacturing companies, foundries, plastic companies, pharmaceutical companies and food and consumer product companies. The Company asserts that it is not responsible for any liabilities of its former subsidiary The Standard Tallow Corporation, which was legally dissolved in 2000, and that, in any event, the Standard Tallow Corporation did not discharge any of the eight contaminants of concern identified in the ROD (the “COCs”). Subsequently, the EPA conducted a settlement analysis using a third-party allocator and offered early cash out settlements to those PRPs for whom the third-party allocator determined did not discharge any of the COCs. The Company participated in this allocation process, and in November 2019, received a cash out settlement offer from the EPA in the amount of $0.6 million ($0.3 million for each of the former plant sites in question) for liabilities relating to the lower 8.3 miles of the Lower Passaic River area. The Company accepted this settlement offer, and the settlement became effective on April 16, 2021 following the completion of the EPA's administrative approval process. In September 2021, the EPA released a ROD selecting an interim remedy for the upper nine miles of the Lower Passaic River at an expected additional cost of $441 million. In October 2022, the Company, along with other settling defendants, entered into a Consent Decree with the EPA pursuant to which the Company paid $0.3 million to settle liabilities for both of the former plant sites in question related to the upper nine miles of the Lower Passaic River. The Company paid this amount into escrow, as the settlement is subject to the EPA’s administrative approval process, which includes publication, a public comment period and court approval. On September 30, 2016, Occidental Chemical Corporation (“OCC”) entered into an agreement with the EPA to perform the remedial design for the cleanup plan for the lower 8.3 miles of the Lower Passaic River. On June 30, 2018, OCC filed a complaint in the United States District Court for the District of New Jersey against over 100 companies, including the Company, seeking cost recovery or contribution for costs under the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”) relating to various investigations and cleanups OCC has conducted or is conducting in connection with the Lower Passaic River. According to the complaint, OCC has incurred or is incurring costs which include the estimated cost to complete the remedial design for the cleanup plan for the lower 8.3 miles of the Lower Passaic River. OCC is also seeking a declaratory judgment to hold the defendants liable for their proper shares of future response costs, including the remedial action for the lower 8.3 miles of the Lower Passaic River. The Company, along with 40 of the other defendants, had previously received a release from OCC of its CERCLA contribution claim of $165 million associated with the costs to design the remedy for the lower 8.3 miles of the Lower Passaic River. Furthermore, the Company’s settlements with the EPA described above could preclude certain of the claims alleged by OCC against the Company. The Company’s ultimate liability, if any, for investigatory costs, remedial costs and/or natural resource damages in connection with the Lower Passaic River area cannot be determined at this time; however, as of the date of this report, the Company has found no definitive evidence that the former Standard Tallow Corporation plant sites contributed any of the COCs to the Passaic River and, therefore, there is nothing that leads the Company to believe that this matter will have a material effect on the Company’s financial position, results of operations or cash flows.

Source: Item 3, 10-K 0000916540-26-000008 vs Item 3, 10-K 0000916540-25-000008

MD&A229 words changed in this paragraph; it is 72% similar to last year's version.
In fiscal 2024, 2025, the Company performed a quantitative approach to valuing goodwill and indefinite-lived intangible assets at October 26, 2024 25, 2025 and as a result determined the fair values of the Company’s reporting units containing goodwill and indefinite lived intangible assets exceeded the related carrying values. However, based on the Company’s annual impairment testing at October 26, 2024, 25, 2025, the fair value of two one of the Company’s six reporting units had a fair value that was not substantially in excess of their carrying values. The fair value of these this reporting units unit was determined to be between 20% - 30% in excess of the carrying value with goodwill of approximately $1.3 billion $563.3 million as of December 28, 2024. January 3, 2026. The Company determined the fair value of reporting units with the assistance of a valuation expert who assisted the Company primarily using the Income Approach to determine the fair value of the Company’s reporting units. Key assumptions that impacted the discounted cash flow model were raw material and sales volumes, gross margins, terminal growth rates and discount rates. It is possible, depending upon a number of factors that are not determinable at this time or within the control of the Company, that the fair value of these two this one reporting units unit could decrease in the future and result in an impairment to goodwill. The Company’s management believes the biggest risk to these this reporting units unit is decreasing finished product prices impacting gross margins and an economic slowdown that would impact raw material suppliers. Upon meeting the criteria for classification of certain of the Company’s assets as held for sale, the Company recorded goodwill charges in the feed segment and food segment of approximately $2.0 million and $17.0 million, respectively. In addition, the Company recorded indefinite lived intangible asset charges in the food segment of approximately $0.2 million. In fiscal 2024, the Company performed a quantitative approach to valuing goodwill and indefinite-lived intangible assets at October 26, 2024. Based on the Company’s annual impairment testing, the Company concluded the fair values of its reporting units containing goodwill and indefinite lived intangible assets exceeded the related carrying values. In fiscal 2023, the Company performed a quantitative approach to valuing goodwill and indefinite-lived intangible assets at October 28, 2023 and as a result determined that fair values of the Company’s reporting units containing goodwill exceeded the related carrying values. In fiscal 2022, the Company performed a qualitative impairment analysis for its annual goodwill and indefinite-lived intangible assets at October 29, 2022. Based on the Company’s annual impairment testing at October 29, 2022, we concluded it is more likely than not that the fair values of the Company’s reporting units containing goodwill exceeded the related carrying value. In fiscal 2022, the Company’s management reviewed our global network of collagen plants for optimization opportunities and decided to close our Peabody, Massachusetts, plant in 2023. As a result of the restructuring, the Company incurred a goodwill impairment charge in the food segment of approximately $2.7 million. Goodwill was approximately $2.5 billion and $2.3 billion at January 3, 2026 and $2.5 billion at December 28, 2024 and December 30, 2023, 2024, respectively.

Source: Item 7, 10-K 0000916540-26-000008 vs Item 7, 10-K 0000916540-25-000008

Accounting Policies157 words changed in this paragraph; it is 31% similar to last year's version.
Entities are required to report all derivative instruments in the statement of financial position at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, if so, on the reason for holding the instrument. If certain conditions are met, entities may elect to designate a derivative instrument as a hedge of exposures to changes in fair value, cash flows or foreign currencies. If the hedged exposure is a cash flow exposure, the gain or loss on the derivative instrument is reported initially as a component of other comprehensive income (outside of earnings) and is subsequently reclassified into earnings when the forecasted transaction affects earnings. Any amounts excluded from the assessment of hedge effectiveness is reported in earnings immediately. If the derivative instrument is not designated as a hedge, the gain or loss is recognized in earnings in the period of change. Hedge accounting treatment ceases if or when the hedge transaction is no longer probable of occurring or the hedge relationship correlation no longer qualifies for hedge accounting.

Source: Item 8, Note 1 – GENERAL, 10-K 0000916540-26-000008 vs Item 8, Note 1 – GENERAL, 10-K 0000916540-25-000008

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of DAR's Risk Factors and MD&A, 10-K Mar 3, 2026 against 10-K Feb 25, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
•Our renewable energy businesses, including the DGD Joint Venture, are highly dependent on government programs, incentives and regulatory frameworks, which are subject to change and uncertainty;
Read it in 10-K Mar 3, 2026 at sec.gov
AddedRisk Factors
The Company’s results of operations in its Feed, Food and Fuel Ingredients segments are also impacted by U.S. and foreign tariffs and trade restrictions that affect trade flows, supply and demand and market prices for the Company’s raw materials and finished products.
Read it in 10-K Mar 3, 2026 at sec.gov
AddedRisk Factors
•U.S. and foreign tariffs, trade restrictions and nationalistic protections in biofuel policies favoring local production over imports could impact prices, margins and end market opportunities for the biofuels the DGD Joint Venture produces;
Read it in 10-K Mar 3, 2026 at sec.gov
AddedRisk Factors
•U.S. and foreign tariffs on biofuels and biofuel feedstocks could also have an inverse effect where biofuel imports into certain countries could be beneficially positioned from a margin standpoint over local production;
Read it in 10-K Mar 3, 2026 at sec.gov
AddedRisk Factors
Our renewable energy businesses, including the DGD Joint Venture, are highly dependent on government programs, incentives and regulatory frameworks, which are subject to change and uncertainty.
Read it in 10-K Mar 3, 2026 at sec.gov
AddedRisk Factors
Demand for and profitability of our biofuels (including renewable diesel and SAF), biogases and green electricity, including those of DGD, depend in significant part on government programs, mandates, tax credits and incentives in the U.S. and other jurisdictions, including renewable fuel standards, low carbon fuel programs and clean fuel tax credits. These programs are complex, subject to frequent legislative, regulatory and administrative change, and dependent on agency interpretation, guidance enforcement priorities and funding.
Read it in 10-K Mar 3, 2026 at sec.gov
Show the other 55
AddedRisk Factors
Government incentives related to renewable fuels were material to our results of operations in fiscal 2025, so any legal challenges or changes to, a failure to enforce, reductions in the mandated volumes under, or suspending or discontinuing any of these programs could have a negative impact on our business and results of operations.
Read it in 10-K Mar 3, 2026 at sec.gov
AddedRisk Factors
•issues associated with intellectual property protections for the Company’s products and operations, such as defense of our intellectual property in foreign countries and/or, as the Company expands globally, use of our intellectual property on competing products in certain countries where our intellectual property is not registered;
Read it in 10-K Mar 3, 2026 at sec.gov
RemovedRisk Factors
•The proposed Employment Rights Bill is set to overhaul employment law in the UK, with a number of employees friendly proposals which could have an adverse effect on our business due to increased costs associated with being an employer;
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedRisk Factors
an event and unscheduled shutdown is restored, there could be no assurance that customers who in the interim choose to use alternative disposal services would return to use our services.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedRisk Factors
The proposed Employment Rights Bill is set to overhaul employment law in the UK, with a number of employee friendly proposals which could have an adverse effect on our business due to increased costs associated with being an employer.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedRisk Factors
On October 10, 2024, the UK government introduced the Employment Rights Bill 2024-25 (the “ER Bill”) to Parliament, aiming to modernize and enhance worker rights through 28 proposed reforms. These reforms are expected to significantly impact UK employment law. The government will consult on these proposals, and changes may occur as the ER Bill progresses through Parliament. Key proposals include the establishment of a new state enforcement body to tackle unlawful employment practices, which would mark a significant shift in UK employment law away from reliance on individual enforcement. Further proposals include making unfair dismissal a right from the first day of employment, changes to redundancy rules and the introduction of new grounds for automatically unfair dismissal to restrict “fire and rehire” practices. In terms of industrial relations, the ER Bill lowers the threshold for trade union recognition and repeals previous restrictions on strike action. For zero hours contracts, it mandates guaranteed hours and reasonable shift notice. Family rights are enhanced with protections for maternity returners, statutory bereavement leave, and the removal of the qualifying period for parental and paternity leave. Statutory Sick Pay reforms include removing the three-day waiting period and a proposal to lower the earnings threshold. These reforms represent a significant shift in favor of employee rights, with detailed consultations expected in 2025 and most reforms unlikely to be implemented until 2026. If enacted, they will bring substantial changes to the UK employment landscape, increasing the costs and risks associated with being an employer, which could in turn have an adverse effect on our business and future operations in the UK.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedRisk Factors
revenues and overall profits. Counterparty risk on finished product sales can also impact revenue and operating profits when customers either are unable to obtain credit or refuse to take delivery of finished products due to market price declines.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedRisk Factors
In the UK and the EU, pension funds are generally subject to the Institution for Occupational Retirement Provision Directive (Directive 2003/41/EC) (the “IORP Directive”) as implemented in the relevant EU Member States (and the UK). The IORP Directive provides for certain general solvency requirements but allows EU Member States discretion to impose specific national requirements. As a result, the solvency of EU pension funds is mostly regulated on a national level. On December 23, 2016, the new IORP Directive (“IORP Directive II”) was published on the Official Journal of the European Union and entered into force on January 12, 2017, though this did not make substantive changes to the solvency requirements under the original IORP Directive. The IORP Directive II recognizes in one of its recitals that changes in this area could potentially decrease the willingness of employers to provide occupational pension schemes. EU Member States were required to implement IORP Directive II into national legislation by January 13, 2019, noting that the IORP Directive was repealed from that date. Pursuant to Article 62.2., letters (a) and (c), of the IORP Directive II, the Commission was required to review and report on the application of the directive by January 13, 2023, to look at the adequacy of the directive “from a prudential and governance point of view” and the impact of the directive on the stability of IORPs. In preparation thereof, the Commission issued a call for technical advice from the European Insurance and Occupational Pensions (“EIOPA”) regarding the evaluation and review of the IORP Directive II. The EIOPA submitted their technical advice on the review on September 28, 2023 where they proposed that the Commission: (a) keeps the regulatory framework for IORPs relevant; (b) recognizes the need for existing defined benefit IORPs to be properly regulated and supervised; and (c) enhance proportionality measures. During the course of 2021, members of the Commission commented that the planned review would likely be postponed until 2024 given that many EU Member States were late in fully transposing the directive (including France, Ireland, Spain and Sweden), and the EIOPA noted in October 2023 that the review may be delayed further until 2025 given upcoming elections at the European Commission. The UK introduced legislation with effect from January 13, 2019 to implement certain parts of IORP Directive II: (i) the Occupational Pension Schemes (Governance) (Amendment) Regulations 2018, SI 2018/1103, which implemented the governance provisions; (ii) the Occupational Pension Schemes (Cross-border Activities) (Amendment) Regulations 2018, SI 2018/1102, which implemented the requirements relating to cross-border activity and cross-border transfers; and (iii) the Pension Protection Fund (Pensionable Service) and Occupational Pension Schemes (Investment and Disclosure) (Amendment and Modification) Regulations 2018, SI 2018/988, which (among other things) made amendments to the content requirements of statements of investment principles so as to require trustees to state, from October 1, 2019, their policy on ‘financially material considerations’. The UK government considered that the other aspects of IORP Directive II were already adequately covered by the existing UK law. Given that IORP Directive II had already been implemented in UK law, the European Union (Withdrawal) Act 2018 (the “EUWA 2018”) had preserved any legislation made in the UK to implement the obligations under IORP Directive II (including those carried over from the IORP Directive). That legislation has not changed following Brexit, and there is not yet indication that the UK legislation and regulation which apply to IORPs will diverge from that of the EU, however this may happen over time, given mechanisms in the EUWA 2018 allow for departure from retained EU case law, and the effect of the Retained EU Law (Revocation and Reform) Act 2023 (the “REUL Act”) (which achieved Royal Assent in the UK on June 29, 2023) on the status, operation and content of retained EU law. Although the REUL Act does not revoke legislation specific to IORPs, other provisions of it, such as the removal of general principles of EU law, may have an impact to the UK’s legislation and regulations which apply to IORPs in the future. In March 2021, the UK Pensions Regulator (“TPR”) published a consultation on its new code of practice, and a draft of the single code (the “Code”), which will cover additional governance requirements to implement IORP Directive II in the UK. The Code will consolidate TPR’s existing codes of practice and introduce new modules to cover the requirements of IORP Directive II (and the underlying UK regulations which implemented the directive). These include the requirement for trustees to have in place remuneration policies and “own risk assessments”, and guidance on topics such as continuity planning. The Code was laid before the UK parliament on January 10, 2024, and came into force on March 28, 2024. The final version of the Code contains new governance requirements and sets out TPR’s expectations of how occupational pension schemes should be managed, but does not differ in any material respect from the draft version of the Code that was introduced in 2021.
Read it in 10-K Feb 25, 2025 at sec.gov
RewordedRisk Factors
Our ability to achieve any stated goal, target, or objective is and will be subject to numerous factors and conditions, including, without limitation, available technology, costs and impacts, new or unforeseen climate events, operational challenges with GHG reduction work, changes in governmental incentives related to GHG reductions, many Many of these factors and conditions are outside of our control, such as evolving regulatory or quasi-regulatory sustainability standards, differing requirements and the pace of changes in technology, and other factors that are not yet known.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedRisk Factors
Furthermore, support Support from renewable identification numbers (“RINs”), LCFS credits, the programs and other government programs play credits plays an important role in the makeup of margins for DGD, and the DGD Joint Venture, and, accordingly, we are exposed to the volatility in the market price of RINs, these credits, including LCFS credits, credits and other credits. RINs (which act as compliance credits under the RFS).
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedRisk Factors
The civil liability risks in Europe in relation to misleading advertising are material, and increasing, and on On December 8, 2024, Directive (EU) 2024/2853, the EU’s revised Product Liability Directive (“PLD”), entered into force, which must be transposed into national legislation of the EU Member States by December 9, 2026. 2026, introduced a number of significant changes that increase liability risks for companies distributing their products to EU consumers.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedRisk Factors
As of December 28, 2024, our total indebtedness, including trade debt, was approximately $4.0 billion and we We also had undrawn commitments available for additional borrowings debt under the our revolving credit facility included as part of our senior secured credit facilities of up to approximately $1.2 $1.3 billion (after giving effect to approximately $267.0 $601.2 million of revolver borrowing, $0.7 $0.8 million of outstanding letters of credit and $72.7 $73.6 million of ancillary facilities).
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedRisk Factors
For instance, while we share certain management rights with our joint venture partner under the DGD LLC Agreement, we do not have full control of every aspect of DGD’s the DGD Joint Venture’s business and certain significant decisions concerning DGD, the DGD Joint Venture require certain approvals from our joint venture partner, including, among others, the acquisition or disposition of assets above a certain value threshold, making certain changes to DGD’s the DGD Joint Venture’s business plan, raising debt or equity capital, DGD’s the DGD Joint Venture’s distribution policy, and entering into particular transactions, also require certain approvals from our joint venture partner. transactions.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedRisk Factors
Our ability to achieve any stated goal, target, or objective is and will be subject to numerous factors and conditions, including, without limitation, available technology, costs and impacts, new or unforeseen climate events, operational challenges with GHG reduction work, work and changes in governmental incentives related to GHG reductions, many factors and conditions outside of our control, such as evolving regulatory or quasi-regulatory sustainability standards, differing requirements and the pace of changes in technology, and other factors that are not yet known. reductions.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedRisk Factors
While our policies mandate compliance with these laws, we cannot provide assurance that These laws generally prohibit companies and individuals from engaging in anticompetitive and unfair business practices, and our internal control policies and procedures will always may not protect us from violations or reckless or criminal acts committed by our employees, joint venture partners or agents.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedRisk Factors
As a producer of meat-centric food products, our business depends on the continued availability of animal by-products and the acceptance of our products in human food, pet food, animal feed and fuel markets, and we are subject to risks associated with the outbreak of disease in pork, beef livestock, and poultry flocks, including Foot-and-Mouth Disease, Avian Influenza Bird Flu, Salmonella and BSE.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedRisk Factors
There can We may not be no assurance as able to whether we could implement future price increases in response to increases in the market prices of raw materials or how materials, and any such price increases would affect may have adverse impacts on future sales volumes to our customers. volumes.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedRisk Factors
Should any of these suppliers choose alternate methods of disposal, cease their operations, have their operations interrupted by casualty, curtail their operations or otherwise cease using our collection services, these operating facilities may be materially and adversely affected, which could materially and adversely affect our business, results of operations and financial condition.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedRisk Factors
In addition, we and our customers may be subject to product liability or other claims, product recalls, and adverse public relations resulting from developments relating to the discovery of unauthorized adulterations to food additives or other products or from allegations that our food ingredients or other products were mislabeled, were not produced in accordance with the customer’s specifications, contract requirements or regulatory standards and/or have not performed adequately in the end product, even where food safety or other product safety is not a concern.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedRisk Factors
In April 2024, the U.S., the EPA adopted a rule designating two widely used PFAS – has designated perfluorooctanoic acid (“PFOA”) and perfluorooctanesulfonic acid (“PFOS”) – as “hazardous substances” under CERCLA and adopted the primary drinking water standard standards for PFAS. certain PFAS, with which public water systems must comply by 2029.
Read it in 10-K Mar 3, 2026 at sec.gov
Quiet changesRisk Factors
We have incurred significant capital and operating expenditures to comply with environmental requirements, including for the upgrade of wastewater treatment facilities, and will may continue to incur such costs in the future.
Read it in 10-K Mar 3, 2026 at sec.gov
Quiet changesRisk Factors
However, EPA regulations limiting exhaust emissions also have become more restrictive, and the National Highway Traffic Safety Administration and the EPA have adopted regulations that govern fuel efficiency and GHG emissions.
Read it in 10-K Mar 3, 2026 at sec.gov
Quiet changesRisk Factors
We can could be subject to potential fines and civil and, in egregious cases, criminal actions if we are found to be in violation of worker health and safety laws in any of these jurisdictions.
Read it in 10-K Mar 3, 2026 at sec.gov
AddedMD&A
We expect tariffs on products imported into the U.S. from Brazil, Canada, China, the European Union and Mexico, and other countries upon which tariffs may be imposed, to continue to be met with retaliatory tariffs from those countries, both of which (U.S. and foreign tariffs) could impact our consolidated results of operations as we export certain of our finished products to and from the U.S. While to date these tariffs have not had a material impact on our results of operations, the extent and duration of tariffs and the resulting impact on macroeconomic conditions and on our business are uncertain and may depend on various factors, including negotiations between the U.S. and affected countries, retaliation imposed by other countries, tariff exemptions, negative sentiment toward U.S. companies and products, and availability of lower cost inputs to our customers. In addition, on February 20, 2026, the Supreme Court of the United States declared some of the existing U.S. tariffs imposed on certain countries unlawful. It remains uncertain how this decision will affect the existing tariffs or whether additional tariffs will be imposed under other laws. Meanwhile, it is also unclear at this point in time as to whether a recovery of previously paid tariffs will be possible; however, if a recovery is possible, the Company and the Company’s DGD Joint Venture may have opportunities for meaningful recoveries. We will continue to evaluate the nature and extent of the impact to our business and consolidated results of operations and actions we can take to minimize their impact.
Read it in 10-K Mar 3, 2026 at sec.gov
AddedMD&A
and ESG practices. We expect that stakeholder expectations with respect to sustainability and ESG expectations will continue to evolve, which may necessitate additional resources to monitor, report on, and adjust our operations.
Read it in 10-K Mar 3, 2026 at sec.gov
AddedMD&A
Fiscal 2025 includes an additional week of operations which occurs every five to six years. In Fiscal 2025 the additional week occurred in the fourth quarter and increased total net sales and operating income by approximately $122.1 million and $9.8 million, respectively.
Read it in 10-K Mar 3, 2026 at sec.gov
AddedMD&A
Segment operating income. The Company’s Fuel Ingredients segment operating income (inclusive of the equity contribution from the DGD Joint Venture) for fiscal year 2025 was $3.4 million, a decrease of $(193.8) million or (98.3)% as compared to fiscal year 2024. The decrease in earnings is due to a combination of factors. Most importantly, the renewable fuel industry experienced a significant change in the regulatory environment including issues related to the change from the blenders tax credit (BTC) to the producers tax credit (PTC) in the United States and tariffs on imported feedstocks, leading to a reduction in incentives and a decrease in margins. In addition, the DGD Joint Venture had lower sales volumes due to three catalyst turnarounds in both of its plants, and a decision to idle its smallest unit due to commercial reasons. In St. Charles, both units experienced turnarounds in the first quarter of fiscal 2025 and the business decided to keep the smaller unit (DGD1) idle following the turnaround due to a low-margin environment. Meanwhile, the unit at Port Arthur underwent a catalyst turnaround in the third quarter of fiscal 2025. Finally, the market mechanisms designed to counterbalance these challenges, including RINs, created through the RFS and state LCFS programs have been slow to react and were unable to offset the decrease in value due to the change from the BTC to the PTC.
Read it in 10-K Mar 3, 2026 at sec.gov
AddedMD&A
The Company’s Board of Directors approved a share repurchase program of up to an aggregate of $500.0 million of the Company’s Common Stock depending on market conditions. The repurchases may be made from time to time on the open market at prevailing market prices or in negotiated transactions off the market. The program runs through August 13, 2026, unless further extended or shortened by the Board of Directors. During fiscal year 2025, the Company repurchased approximately $34.7 million, including commissions, of its common stock in the open market. As of January 3, 2026, the Company had approximately $460.3 million remaining in its share repurchase program.
Read it in 10-K Mar 3, 2026 at sec.gov
RemovedMD&A
Canada, Darling NL, Darling Ingredients International Holding B.V. (“Darling BV”), Darling GmbH, and Darling Belgium in U.S. dollars, Canadian dollars, euros, Sterling and other currencies to be agreed and available to each applicable lender. The remaining $40.0 million must be borrowed in U.S. dollars only by Darling. The revolving credit facility will mature on December 9, 2026. The revolving credit facility will be used for working capital needs, general corporate purposes and other purposes not prohibited by the Amended Credit Agreement. For more information regarding the Amended Credit Agreement see Note 10 of Notes to Consolidated Financial Statements included herein.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
Additionally, the Company has made required and tax deductible discretionary contributions to its foreign pension plans in fiscal year 2024 of approximately $3.3 million, as compared to $4.1 million in contributions in fiscal year 2023.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
Loan Agreement. This note receivable amount when outstanding is included in other current assets on the balance sheet and is included in investing activities on the cash flow statement.
Read it in 10-K Feb 25, 2025 at sec.gov
RewordedMD&A
The Amended Credit Agreement refinanced the loans and commitments outstanding under the Previous Credit Agreement and provides for senior secured credit facilities in the aggregate principal amount of $3.725 billion, which matures on December 9, 2026 and is $2.9 billion comprised of (i) the Company’s $525.0 $900.0 million six-year term A facility (partially comprised of $395.0 million term loan B facility, A-1 facility and $296.3 million term A-3 facility which, in each case, were cashlessly rolled from the Previous Credit Agreement) and (ii) the Company’s $400.0 million term A-1 facility, (iii) the Company’s $500.0 million term A-2 facility, (iv) the Company’s $300.0 million term A-3 facility, (v) the Company’s $500.0 million term A-4 facility and (vi) the Company’s $1.5 $2.0 billion five-year revolving credit facility (up to $50.0 million (as such amount may be increased to an amount not exceeding $150.0 million to the extent consented to by the applicable issuing banks) of which will be available for a letter of credit sub-limit subfacility and up to $50.0 million of which will be available for a swingline sub-limit) sub-facility) (collectively, the “Senior Secured Credit Facilities”).
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedMD&A
In addition to those factors discussed under the heading “Risk Factors” in Item 1A of this report and elsewhere in this report, and in the Company’s other public filings with the SEC, important factors that could cause actual results to differ materially from the Company’s expectations include: existing and unknown future limitations on the ability of the Company’s direct and indirect subsidiaries to make their cash flow available to the Company for payments on the Company’s indebtedness or other purposes; reduced demands or prices for biofuels, biogases or renewable electricity; global demands for grain and oilseed commodities, which have exhibited volatility, and can impact the cost of feed for cattle, hogs and poultry, thus affecting available rendering feedstock and selling prices for the Company’s products; reductions in raw material volumes available to the Company due to weak margins in the meat production industry as a result of higher feed costs, reduced consumer demand, reduced volume due to government regulations affecting animal production or other factors, reduced volume from food service establishments, or otherwise; reduced demand for animal feed; reduced finished product prices, including a decline in fat, used cooking oil, protein or collagen (including, without limitation, collagen peptides and gelatin) finished product prices; changes to government policies around the world relating to renewable fuels and GHG emissions that adversely affect prices, margins or markets (including for the DGD Joint Venture), including programs like renewable fuel standards, low carbon fuel standards (“LCFS”), renewable fuel mandates and tax credits for biofuels or loss or diminishment of tax credits due to failure to satisfy any eligibility requirements, including, without limitation, in relation to the blenders tax credit or CFPC; climate related adverse results, including with respect to the Company’s climate goals, targets or commitments; possible product recall resulting from
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedMD&A
Fiscal Year Ended (dollars in thousands) January 3, December 28, December 30, 2026 2024 2023 Net income attributable to Darling $ 62,804 $ 278,880 $ 647,726 Depreciation and amortization 508,504 503,825 502,015 Interest expense 222,279 253,858 259,223 Income tax expense/(benefit) benefit (9,359) (38,337) 59,568 Restructuring and asset impairment charges 57,960 5,794 18,553 Acquisition and integration costs 15,942 7,842 13,884 Change in fair value of contingent consideration 18,024 (46,706) (7,891) Foreign currency losses/(gains) losses 384 1,154 (8,133) Other income, net (468) (22,309) (16,310) Debt extinguishment costs 2,978 — Equity in net income (income)/loss of Diamond Green Diesel 48,770 (149,082) (366,380) Equity in net income of other unconsolidated subsidiaries (12,759) (11,994) (5,011) Net income attributable to noncontrolling interests 7,581 6,965 12,663 Adjusted EBITDA (Non-GAAP) $ 922,640 $ 789,890 $ 1,109,907 Foreign currency exchange impact (1) 1,334 (20,420) — Pro forma Adjusted EBITDA to Foreign Currency (Non-GAAP) $ 791,224 902,220 $ 1,109,907 789,890 DGD Adjusted EBITDA (Darling's Share) (Non-GAAP) $ 103,716 $ 289,945 $ 501,987 Combined Adjusted EBITDA (Non-GAAP) $ 1,026,356 $ 1,079,835 $ 1,611,894
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedMD&A
The decrease increase was primarily due to lower overall higher finished product prices good fat prices, higher sales volumes and operational improvements that more than offset a decrease an increase in selling, general and administrative expenses expenses, an increase in restructuring and a gain from impairment charges primarily related to the reduction strategic realignment of the recorded FASA our Enviroflight operations of approximately $29.2 million and an increase in contingent consideration liability as compared to fiscal year 2023. 2024.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedMD&A
(“Darling NL”) Holding”) entered into a Third Amended and Restated Credit Agreement (the “Amended Credit Agreement”), which amended and restated the Company’s then existing Second Amended and Restated Credit Agreement dated January 6, 2014 (as subsequently amended, amended from time to time, the “Amended “Previous Credit Agreement”), restating its then existing Amended and Restated Credit Agreement dated September 27, 2013, with the lenders from time to time party thereto, JPMorgan Chase Bank, N.A., as Administrative Agent, and the other agents from time to time party thereto.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedMD&A
Sales prices for many of the principal products that the Company sells are typically influenced by sales prices for agricultural-based ingredients, the prices of which are based on established commodity markets and are subject to volatile changes. changes, and sales prices for the principal products that DGD sells are typically influenced by the demand and pricing of renewable diesel, which is dependent on governmental energy policies and programs and impacted by the value of RINS and LCFS credits stemming from such governmental energy policies and programs.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedMD&A
The decrease in interest expense is primarily due to less interest on term loan A facilities and other notes due to reductions in amounts outstanding from payments made that were partially offset by an increase in revolver lower interest paid on term loan debt as a result of higher the reduction of the term loan balances outstanding which slightly lowered our average revolver borrowings debt outstanding during fiscal year 2024 2025 as compared to fiscal year 2023. 2024.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedMD&A
Net cash provided/(used) used in financing activities was $(399.6) $376.7 million during fiscal year 2024, 2025, compared to $876.3 $399.6 million in fiscal year 2023, 2024, a decrease in net cash provided used of $1,275.9 $22.9 million, primarily due to lower debt borrowings repayments that were used more than offset an increase in contingent consideration payments, acquisition of noncontrolling interests and acquisition holdback payments as compared to fund acquisitions in the prior year.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedMD&A
Net cash provided by operating activities was $839.3 $1,059.7 million and $899.3 $839.3 million for the fiscal years ended January 3, 2026 and December 28, 2024 and December 30, 2023, 2024, respectively, a decrease an increase of $60.0 $220.4 million due primarily to a decrease in net income that more than offset an increase in cash distributions from working capital. unconsolidated subsidiaries.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedMD&A
Cash Net cash used in investing activities was $498.9 $681.4 million during fiscal year 2024, 2025, compared to $1,675.5 $498.9 million in fiscal year 2023, a decrease 2024, an increase in cash used of $1,176.6 $182.5 million, primarily due to an increase in contributions to the DGD Joint Venture that more than offset a decrease in acquisitions and capital expenditures. acquisitions.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedMD&A
National Renewable Fuel Standard Program (“RFS”) RFS and low carbon fuel standards (“LCFS”) LCFS (such as those in place in the state of California), California) and tax credits for biofuels and mandates for biofuel use both in the United States and abroad abroad, such as IR Acts’s 45Z and European Union’s renewable energy directive (RED III), are subject to revision and change which may impact the demand for and/or price of our finished products.
Read it in 10-K Mar 3, 2026 at sec.gov
RewordedMD&A
In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures, Disclosures (Subtopic 220-40), which requires new disclosures providing further detail entities to disaggregate any relevant expense caption presented on the face of a Company’s the income statement expense line items. within continuing operations or in the footnotes.
Read it in 10-K Mar 3, 2026 at sec.gov
Quiet changesMD&A
The Company is currently evaluating this ASU to determine its impact on the Company’s disclosure, but does not expect this update to have a material impact on the Company’s consolidated financial statements other than additional information that is will be provided in the footnote disclosure.
Read it in 10-K Mar 3, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/DAR/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.